NPM1 mutation is a stable marker for minimal residual disease monitoring in acute myeloid leukaemia patients with increased sensitivity compared to WT1 expression
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Michael Boe Møller |
| Publication date | August 11, 2011 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |